Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. MSFT
6. DCOY
7. VKTX
8. PRGS
9. VRTX
10. IONQ

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
INSMED (NASDAQ: INSM) Delayed: 120.82 -0.18 (0.15%)
Previous Close $121.00    52 Week High $19.30 
Open $121.75    52 Week Low $9.02 
Day High $122.48    P/E N/A 
Day Low $119.09    EPS $-1.69 
Volume 2,405,267